NCT01270490View on ClinicalTrials.gov

Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia

PHASE3UnknownINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

January 31, 2013

Conditions

Candidemia

Interventions

DRUG

Interferon-gamma, Recombinant

Interferon 50 mcg/m2 to be administered three times per week during two weeks

Trial Locations (1)

6525 GA

RECRUITING

Radboud University Medical Centre Nijmegen, Nijmegen

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

BioMérieux

INDUSTRY

lead

Radboud University Medical Center

OTHER